To our knowledge, LUZP1, the cavins, and syncoilin have no prior links to skeletal muscle atrophy; however, a recent study suggests that BRD4 activity in skeletal muscle may contribute to cancer-induced skeletal muscle atrophy (55). Here, LUZP1 is linked to cancer.